Abnormalities of T cell signaling in systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Abnormalities of T cell signaling in systemic lupus erythematosus.

Abnormalities of T cell signaling in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35092855

about

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway Targeting Syk in Autoimmune Rheumatic Diseases mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging The pathogenesis of systemic lupus erythematosus—an update The pathology of T cells in systemic lupus erythematosus Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.Changes in Frequency and Activation Status of Major CD4+ T-Cell Subsets after Initiation of Immunosuppressive Therapy in a Patient with New Diagnosis Childhood-Onset Systemic Lupus Erythematosus.Estradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?Getting Syk: spleen tyrosine kinase as a therapeutic target.Oxidative stress, T cell DNA methylation, and lupus.The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infection Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis.RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy.Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.The janus head of T cell aging - autoimmunity and immunodeficiency.The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Fas(lpr) mice.Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus.Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: A nationwide population-based retrospective cohort study.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.Elevated expression of TIGIT on CD3+CD4+ T cells correlates with disease activity in systemic lupus erythematosus.NFAT gene family in inflammation and cancer.Genetics and autoantibodies.Autoantigens: novel forms and presentation to the immune system.HDL in innate and adaptive immunity.Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus.

P2860

Q26746697-93F47B2C-1B16-4399-B071-32E98B1E15C6 Q26751042-F59722B3-F1F1-421B-B6D7-5049B60E9DE5 Q28081442-6B44F336-93C8-48AC-A48B-4F1AB736C274 Q29394347-7FE8F534-2A17-487B-8B54-2A2AE20B1E1B Q33598213-2B0671E0-0036-415C-97E6-7BEF82A1566C Q33619322-4878012F-1838-4D93-82D1-94CD6ED45511 Q33680451-1E2A4897-0605-4BED-8A9B-2427F44B1392 Q33810803-D00DBC91-150E-4EC9-9100-32783F6ACD73 Q33993750-A6506573-495E-44C4-81B3-77148A918D2D Q34077487-8E76E659-7E5C-4D5B-91A7-3B00AEEE16F0 Q34284885-AE38C9FA-D29A-4E69-A949-8CD7F23FA15F Q34322605-0D65AE4B-A632-4848-AF7F-CB092542B7C6 Q34435073-DF8B26AD-BD13-4000-8DC3-76CAC5C64674 Q34990559-E729DDD8-B6D1-4F9B-BA6D-B2B208579669 Q35210660-A5D6E84B-3DA0-4CBA-ADC5-251C0BD5ECA9 Q35606420-6F8A7988-32CD-4BC5-AFA9-97F018A4A482 Q35680908-AFD523A2-62FC-4B11-BE59-B2D25A767C8F Q35747810-F02336D1-4869-4870-85E6-5FD3986E6E8C Q35836112-77A9F78A-BDD4-43EA-8B5F-6A4F6E7430F1 Q36002595-0F80EF96-3391-47C3-B9AD-CD9C35BBAC96 Q36190001-76263BE8-0EFB-4086-AD13-FC4D1691C968 Q36329834-CA7527BD-6DAF-40C9-A8DF-65376DAEBF94 Q36511431-5440022F-AADF-4771-B5C8-463092BF6053 Q36712941-8ADA6C91-E22C-4A8B-BE5A-FF038C0BD61D Q36898613-72EAFAAE-A287-4DE3-AAAD-2275A9AE3DFA Q37048453-7B3E5CC4-61B2-42F8-88C3-2307FC99E143 Q37058781-919704F4-C20D-4AC0-88A7-D11314392D67 Q37118090-5CCFD7CA-8F50-4937-B2DA-BD56EC76D977 Q37524224-67E65ED2-7505-4338-BBC0-5AD8C6D6933C Q37543817-8006BEF5-3E9E-4C64-B173-6867DC513B3A Q37583493-C8D3E3B8-ABCF-4A4D-A42B-B0411AB43485 Q37599137-E144992A-9BEA-4CE0-98FC-85FAFA18E462 Q37605722-F54C9DB4-51D5-4D06-993F-E2921E055B97 Q37649641-1A314B5D-9C82-4113-BA31-3951EC1A3C51 Q37673346-032D3A2C-092A-4382-91EB-AA9A523B3D60 Q38040813-85407493-8776-4505-AB57-0E6C5CDC84A7 Q38096937-800E34C3-8A13-4E9C-B408-B59A83E5A849 Q38160040-59942235-3B1C-4730-9F6C-BF844425E9FF Q38220759-ED7967E3-F141-476A-9960-CC4B18950DF4 Q38818994-49DBD37E-1A8D-4C84-A681-09D0989CA937

P2860

Abnormalities of T cell signaling in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35092855

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Abnormalities of T cell signaling in systemic lupus erythematosus.

@ast

Abnormalities of T cell signaling in systemic lupus erythematosus.

@en

type

label

Abnormalities of T cell signaling in systemic lupus erythematosus.

@ast

Abnormalities of T cell signaling in systemic lupus erythematosus.

@en

prefLabel

Abnormalities of T cell signaling in systemic lupus erythematosus.

@ast

Abnormalities of T cell signaling in systemic lupus erythematosus.

@en

P1433

Q35092855-C25C0AD3-08F3-4263-893C-D2395DC44FE1

P1476

Q35092855-45EE0D23-B06E-40FE-9CF9-50BC14732D1A

P2093

Q35092855-2E38073E-896F-43B9-9142-AC8EF1ECCDEC

Q35092855-5FB7976D-893B-426A-893F-D0F6B3D04813

P2860

Q35092855-00B453EF-B8BD-4D58-BD44-11386DA011BD

Q35092855-018DFFE4-5D8C-457E-8252-5191B58F7C2C

Q35092855-0E3B16D7-688A-4218-A789-CCF980D8AEDE

Q35092855-1297CC1B-48E6-4AAE-9AF4-7751C1B3BFAC

Q35092855-20654C16-79CE-4A60-9877-762A21E0774A

Q35092855-2411B28F-F92F-4FA4-90E3-F043A1DFFACC

Q35092855-282BDFCB-BB48-4813-85FF-3250CAF62834

Q35092855-2EB87B89-1C15-4413-8684-1AB72558A8A8

Q35092855-30588AAD-1F93-4ADF-B3DF-9E4C7A8BE0EF

Q35092855-3083B702-AC52-4872-8362-AFC1E91AC826

P2888

Q35092855-B178880F-0A2C-4F8F-9D75-299356519A4E

P304

Q35092855-E0732A87-CD7B-4FED-B636-ADD46C357A25

P31

Q35092855-342AADE5-0DAF-4337-9BEE-AD1F6BB909D1

Q35092855-C5E1B93D-ECDD-476D-8F8B-D97F82DFB572

P356

Q35092855-EA476B18-433A-4E23-B6B4-77CDD487D0F2

P433

Q35092855-E8044931-CD53-4B25-95D5-6FE5C84CBCE0

P478

Q35092855-BA28D9C4-2954-441B-A3FD-D2917797C0CC

P577

Q35092855-B8EE9347-C08F-4BBE-9426-37C91F4E5391

P5875

Q35092855-7062EAB1-9B99-4880-8082-066EF6C6B22A

P6179

Q35092855-808472A9-CE16-4767-90B7-42E254E5A6D8

P698

Q35092855-219C482D-C126-4B2C-899D-22066C184639

P921

Q35092855-235AB2B1-EFB4-4674-B725-BDDC080DEA31

Q35092855-3977B0DF-458E-456E-A738-5C2F3A1401B0

Q35092855-3A760DD7-F007-49A7-AEC5-63D392BAEF6E

P932

Q35092855-4E7B9113-36CC-447E-B6DE-EF6D30C0F935

P356

P1433

Arthritis Research and Therapy

P1476

Abnormalities of T cell signaling in systemic lupus erythematosus.

@en

P2093

George C Tsokos

http://www.w3.org/2001/XMLSchema#string

Vaishali R Moulton

http://www.w3.org/2001/XMLSchema#string

P2860

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

Development, cytokine profile and function of human interleukin 17-producing helper T cells

AP-1 function and regulation

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.

Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.

Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.

Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice

Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

P2888

P304

207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3251

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50986564

http://www.w3.org/2001/XMLSchema#string

P6179

1048217432

http://www.w3.org/2001/XMLSchema#string

P698

21457530

http://www.w3.org/2001/XMLSchema#string

P921

systemic lupus erythematosus

hemic and immune systems

P932

3132009

http://www.w3.org/2001/XMLSchema#string